| Literature DB >> 21794168 |
David Gonzalez-Ballester1, Wirulda Pootakham, Florence Mus, Wenqiang Yang, Claudia Catalanotti, Leonardo Magneschi, Amaury de Montaigu, Jose J Higuera, Matthew Prior, Aurora Galván, Emilio Fernandez, Arthur R Grossman.
Abstract
A method was developed to identify insertional mutants of Chlamydomonas reinhardtii disrupted for selected target genes. The approach relies on the generation of thousands of transformants followed by PCR-based screenings that allow for identification of strains harboring the introduced marker gene within specific genes of interest. Our results highlight the strengths and limitations of two independent screens that differed in the nature of the marker DNA used (PCR-amplified fragment containing the plasmid-free marker versus entire linearized plasmid with the marker) and in the strategies used to maintain and store transformants.Entities:
Year: 2011 PMID: 21794168 PMCID: PMC3161022 DOI: 10.1186/1746-4811-7-24
Source DB: PubMed Journal: Plant Methods ISSN: 1746-4811 Impact factor: 4.993
Main features of transformant libraries used for identification of strains harboring specific gene disruptions
| Number of transformants generated | Marker used for transformation | Transformation method | Indexing method | Preservation method | Reference | |
|---|---|---|---|---|---|---|
| ~100,000 | electroporation | individuals | none | [ | ||
| ~22,000 | glass beads | pools of 96 | cryopreservation | [ |
Figure 1Primer design. Depicted is an actual case of the Chlamydomonas RDP3 target gene (ID, 183511) interrupted by the marker gene. The marker gene consisted of a PCR-amplified fragment containing the AphVIII gene under the control of the PSAD promoter, and with an incomplete 3'UTR. Since the DNA marker can be integrated into the Chlamydomonas genome in two different orientations, two forward (F1 and F2) and two reverse target gene primers (R1 and R2) were used to identify the insertion site. Typically, forward and reverse primers are separated by ~1.0 kb along the sequence of the target gene. Each target gene primer is used in combination with individual marker gene primers (RB1 and RB2) in independent PCR amplifications. Amplification would only be possible in those transformants in which the marker gene is inserted close to or within the target gene. In the example depicted, the marker gene was inserted within the 5'UTR of the target gene and amplification was observed with the RB2-R1 primer pair. Exons, introns and UTR regions are represented by black, white and grey squares respectively.
Figure 2Work-flow diagram used for the reverse genetics approach. . Thousands of transformants are generated using the AphVIII marker gene and selected on paromomycin-containing plates. . Individual colonies are cultured in 96-well microtiter plates (200 μl per well). . Aliquots (25-50 μl) from each well of an individual 96 well microtiter plate are pooled and cultured in fresh medium (pool). . DNA from each pool of transformants is isolated and diluted to 100 ng/μL. . Superpools are constructed by combining equal volumes of genomic DNA from 10 different pools. . A set of independent PCR reactions using marker and target gene primers is performed with each DNA superpool as template (in the real case depicted, amplification occurred in the superpool sample loaded in lane 16) . Amplified PCR products are sequenced using the marker gene primer. . The 10 different pools of DNA that comprise the superpool are individually screened using the appropriate primer pair. . Positive transformants are identified within a specific microtiter plate by colony PCR. . Cells from the well containing the positive transformant are streaked onto solid medium to obtain single cell-derived colonies, which are then screened by colony PCR. This step is used to eliminate potential cross-contamination among transformants.
Benefits of the use of plasmid-free markers relative to an entire plasmid harboring a marker gene when performing reverse genetic screens.
| Distance from the inserted marker gene to the host genomic DNA | Stability of the maker primer binding sites on the integrated marker DNA | Risk of non-selectable insertions (partial plasmid sequences or incomplete marker genes) | |
|---|---|---|---|
| Short (as short as few bp) for both borders of the marker DNA | Stable if placed within the marker gene coding sequence | Low1 | |
| Long (up to few kb) for at least one border of the marker DNA | Can be lost if placed close to the borders of the linearized vector | High2 |
1Rearrangement in, or fragmentation of the introduced marker would eliminate the drug resistance selection; no transformant would be identified. 2Rearrangements and fragmentation could occur that would leave the marker gene intact, which would allow fragments of non-selectable DNA to integrate into the genome and cause secondary mutations.
Figure 3Determination of marker gene copy number by Southern blot hybridization. Southern-blot analysis of digested (PstI) genomic DNA from 9 randomly isolated paromomycin resistant mutants. A fragment of the AphVIII gene labeled with 32P-dNTPs was used as probe. As shown, most transformants have a single copy of the integrated marker gene. Only the transformant represented in lane 4 may have two insertions (indicated by the two hybridizing bands). p.s., parental strain used to obtain the transformants.
Number of insertions identified and transformants isolated in Libraries 1 and 2.
| 63 | 64 | 52 | 45 | 37 | |
| 7 | 4 | 4 | 2 | 2 | |
Sizes of genomic deletions generated by insertion of the marker gene.
| 0 (×23), 2, 3, 4, 5 (×2), 8, 12 15, 34 | 32 | |
| 0 (×3), 12, 22, 200, 4178, 5000, 10000, 12000, 35000 | 11 | |
n, number of transformants analyzed. x, the number of times that the specified deletion size was found. 0 denotes that the insertion was 'true' with no deletion at either flank. *some deletion size analyses were noted for transformants isolated by forward genetic screens not described in this manuscript [36-38].
Isolated transformants.
| Interrupted gene | ID1 | Library | Localization and orientation of the insertion2 | Deletion size at the genomic region (bp) | Expression of the interrupted gene |
|---|---|---|---|---|---|
| 183511 | 1 | 5'UTR, + | n.a. | n.a. | |
| 206110 | 1 | 1st exon, + | 0 | truncated and co-expressed with the marker as a chimeric mRNA | |
| 127464 | 1 | 2nd intron, + | 0 | truncated and co-expressed with the marker as a chimeric mRNA. Low expression levels relative to the parental strain | |
| 77600 | 1 | 3rd exon, - | n.a. | mRNA not detected | |
| 182794 | 1 | 4th exon,+ | n.a. | n.a. | |
| 205514 | 1 | 1st exon, + | 0 | truncated and co-expressed with the marker as a chimeric mRNA. | |
| 420357 | 1 | 3'UTR, + | 8 | n.a. | |
| 420357 | 1 | promoter, + | 3 | n.a. | |
| 420357 | 1 | 17th exon, + | 0 | truncated and co-expressed with the marker as a chimeric mRNA | |
| 150514 | 1 | 9th exon, - | 0 | truncated and co-expressed with the marker as chimeric mRNA; transcript has a premature stop codon after splicing | |
| 205502 | 1 | 8th exon, + | 0 | truncated and co-expressed with the marker as chimeric mRNA | |
| 205502 | 2 | promoter, + | 12,000 | n.a. | |
| 205501 | 1 | 5'UTR, + | 0 | low expression levels relative to the parental strain | |
| 206677 | 1 | 7th exon, + | 0 | truncated and co-expressed with the marker as a chimeric mRNA | |
| 206677 | 1 | 1st intron, - | 12 | low expression levels relative to the parental strain | |
| 206677 | 1 | 5'UTR, - | 0 | low expression levels relative to the parental strain | |
| 145357 | 1 | 5'UTR, + | n.a. | n.a. | |
| 196831 | 1 | 6th exon, + | 0 | n.a. | |
| 183963 | 1 | 5'UTR, + | n.a. | n.a. | |
| 183963 | 1 | 3'UTR, - | 2 | n.a. | |
| 24189 | 1 | 9th exon, + | 0 | n.a. | |
| 193810 | 1 | 5th introns, - | n.a | n.a | |
| 147682 | 1 | 4th exon, + | 0 | n.a. | |
| 147682 | 1 | 7th exon, + | 4 | n.a. | |
| 139758 | 1 | 3'UTR, - | 0 | n.a. | |
| 139758 | 1 | 3'UTR, - | n.a. | n.a. | |
| 196270 | 1 | 3rd intron, + | 0 | n.a. | |
| 163170 | 1 | 5'UTR, - | n.a. | n.a. | |
| 188740 | 1 | 2nd exon, + | 15 | n.a. | |
| 206683 | 1 | 3rd exon, + | 0 | n.a. | |
| 111255 | 1 | 7th exon, + | 7 | n.a. | |
| 182877 | 1 | 3'UTR, - | 0 | n.a. | |
| 148255 | 1 | 3'UTR, - | 34 | n.a. | |
| 536345 | 1 | 15th exon, - | 0 | no protein detected | |
| 419232 | 1 | promoter, + | 0 | n.a. | |
| 419232 | 1 | promoter, + | 0 | n.a. | |
| 158745 | 2 | 3'UTR, - | n.a. | n.a. | |
| 195417 | 1 | 3'UTR, + | n.a. | n.a. | |
| 174928 | 1 | 16th exon, + | n.a. | n.a. | |
| 524057 | 1 | 17th exon, + | 0 | n.a. | |
| 34332 | 1 | 2nd exon, + | 0 | n.a. | |
| 523148 | 1 | 3'UTR, + | n.a. | n.a. | |
| 60710 | 1 | 23rd exon, + | n.a. | n.a. | |
| 196818 | 1 | 2nd exon, - | n.a. | n.a. | |
| 196829 | 1 | 16th exon, + | 0 | n.a. | |
| 190023 | 1 | 3'UTR, - | 1 | n.a. | |
| 140337 | 1 | 5'UTR, + | n.a. | n.a. | |
1Protein IDs from the Joint Genome Institute Chlamydomonas v.4 website. 2Localization and orientation of the inserted marker gene relative to the interrupted target gene: + and - denote the same and opposite orientation, respectively. Independent insertion alleles for the same target gene are indicated by the same gene designation, but with a different number placed in a parenthesis. n.a.: not analyzed.